-

Hims & Hers Launches Holiday Gift Sets for Hair and Skin

The digital wellness brand is offering discounts on some of its best-selling hair and skin products, just in time for the holidays

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform that provides modern personalized health and wellness experiences to consumers, today announced bundles of some of their top-selling skin and hair products, perfect for all types of gifting needs this holiday season.

Hims & Hers is making their top-quality products even more accessible to consumers with their holiday gift sets that include a 30% discount off of the original individual pricing, making it easier than ever to get radiant skin and luscious, thicker-looking locks during a time when many are looking for a refresh as we inch towards a new year.

Along with the wellness bundles, the holiday lineup continues with the Hims Cologne, a small batch scent inspired by road trips in Coastal California, which will be available at 50% off ($32). Other individual items will be at a 20% discount.

“Consumers are regularly asking us to provide gifting options around the holidays so they can share their love of Hims & Hers health and wellness products with their family and friends,” said Hilary Coles, co-founder and SVP of Brand & Innovation, Hims & Hers. “That’s why we are excited to be bundling some of our top over-the-counter items for easy access to wellness needs this holiday season.”

For more information on these bundles, please visit www.forhims.com/holiday-gift-guide-2021.

About Hims & Hers

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Launched in November 2017, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers is able to provide access to quality, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco, California. For more information about Hims & Hers, please visit forhims.com and forhers.com.

Contacts

Jess Haro Rodriguez
press@forhims.com

Hims & Hers Health, Inc.

NYSE:HIMS

Release Summary
Hims & Hers announced bundles of some of their top-selling skin and hair products, perfect for all types of gifting needs this holiday season.
Release Versions

Contacts

Jess Haro Rodriguez
press@forhims.com

More News From Hims & Hers Health, Inc.

Hims & Hers Names Kathryn Beiser as Chief Communications Officer

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced the appointment of Kathryn Beiser as Chief Communications Officer. In this role, Beiser will lead external and internal communications for the company as it enters a new phase of domestic and international growth. In her role as CCO, Beiser will report to CEO Andrew Dudum and focus on continuing to build the Hims & Hers brand and reputation while helpin...

Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Hims & Hers Benefits, a new way for subscribers to access the best innovations in whole body health. This new initiative provides active subscribers access to discounts from health partners, all in one place, including whole body MRI scans from Prenuvo and adaptive bed systems from Eight Sleep. This is just the beginning of a larger benefits program that will...

Hims & Hers Announces Strategic Shift for US Weight Loss Business

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) today announced a collaboration with Novo Nordisk as part of a new strategy for weight loss care treatments involving GLP-1s, evolving its US offering to match the company’s approach globally. In the US, the company now plans to provide GLP-1 customers with access to a broad assortment of FDA-approved medications and offer compounded semaglutide through the platform on a limited scale. By aligning its domestic and interna...
Back to Newsroom